Egypt, WHO representative discuss ways of cooperation in mRNA technology in medicine production



Fri, 13 Jan 2023 - 03:07 GMT


Fri, 13 Jan 2023 - 03:07 GMT

The move comes in the framework of combating black market activities in medicines – Image courtesy of Pixabay

The move comes in the framework of combating black market activities in medicines – Image courtesy of Pixabay

CAIRO – 13 January 2023: Egyptian Minister of Health Khaled Abdel Ghaffar and the World Health Organization (WHO) Representative in Egypt Naeema Al-Jasseer discussed ways of cooperation in developing the drug and vaccine production system with the WHO and other international companies.


The meeting discussed work on transferring expertise and advanced manufacturing of mRNA technology in the production of medicines, especially for the treatment of chronic diseases, as well as vaccines and serums, Abdel Ghaffar said in a statement on Thursday.


The Minister noted that it was agreed to organize a number of joint meetings during the coming period to coordinate work mechanisms, in addition to organizing a visit by World Health Organization experts to the factories of the Holding Company for Biopharmaceuticals and Vaccines, “Vacsera”, to review the production lines of serums and pharmaceuticals.


Al Qaseer, voiced her appreciation to the Minister of Health and Population for his constant efforts to improve all aspects of the health system.


In February 2022, World Health Organization Director-General Tedros Adhanom Ghebreyesus announced that six African countries including Egyptian Tunisia would receive “mRNA” technology to produce vaccines against the Coronavirus locally.


At the European Union - African Union summit in Brussels, Tedros Adhanom announced the first African six countries that would receive this technology. The countries are Egypt, Kenya, Nigeria, Senegal, South Africa and Tunisia.


President Abdel Fattah El Sisi expressed his appreciation for Egypt being selected to be among the countries of the African continent that will receive the support to obtain the mRNA technology used in the manufacturing of vaccines and other important medical drugs to confront many incurable diseases.


President Sisi’s appreciation was voiced in his speech at the WHO Session on Vaccine Technology and Health Systems, on the sidelines of the EU-AU summit in Brussels in February.




Leave a Comment

Be Social